Prevalence of Lymphoma in IBD

Indiana University

Status: Completed

Conditions: Inflammatory Bowel Disease; Lymphoma

Study type: Observational

Funder types: Other

Identifiers

NCT00577538

IRB# 0603-58

060358

Details and patient eligibility

About

Patients with inflammatory bowel disease (IBD) may be at increased risk of lymphoma. The majority of lymphomas in patients with IBD occur in areas of active inflammation. The relationship between IBD and lymphoproliferative disease is however unclear, since both chronic inflammation as well as medications used to treat IBD (especially immunosuppressives - Azathioprine or 6-MP - and anti-TNF alpha agents) have been associated with increased risk of lymphoma. We plan to study the association between IBD and lymphoma in a large, mixed, community based and referral population from the IBD database at Indiana University.

Enrollment: 7 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Inflammatory Bowel disease
• Lymphoma

Trial design

7 participants in 2 patient groups

1

2